Micafunginbehandling var forbundet med signifikant forværring af leverfunktion (forhøjet ALAT, ASAT eller total bilirubin > 3 gange ULN) både hos raske frivillige og hos patienter.
Micafungin treatment was associated with significant impairment of liver function (increase of ALT, AST or total bilirubin > 3 times ULN) in both healthy volunteers and patients.